These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 35856508)

  • 21. S-Glutathionylation and S-Nitrosylation in Mitochondria: Focus on Homeostasis and Neurodegenerative Diseases.
    Vrettou S; Wirth B
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria as targets for chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Apoptosis; 2009 Apr; 14(4):624-40. PubMed ID: 19205885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approaches to Mitigate Mitochondrial Dysfunction in Sensorineural Hearing Loss.
    Okur MN; Djalilian HR
    Ann Biomed Eng; 2022 Dec; 50(12):1762-1770. PubMed ID: 36369597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.
    Rossi L; Lombardo MF; Ciriolo MR; Rotilio G
    Neurochem Res; 2004 Mar; 29(3):493-504. PubMed ID: 15038597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT3 and mitochondrial metabolism in neurodegenerative diseases.
    Salvatori I; Valle C; Ferri A; Carrì MT
    Neurochem Int; 2017 Oct; 109():184-192. PubMed ID: 28449871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunction in neurodegenerative disorders.
    Klemmensen MM; Borrowman SH; Pearce C; Pyles B; Chandra B
    Neurotherapeutics; 2024 Jan; 21(1):e00292. PubMed ID: 38241161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases.
    Li X; Huang L; Lan J; Feng X; Li P; Wu L; Peng Y
    Pharmacol Res; 2021 Jan; 163():105240. PubMed ID: 33053441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria at the interface between neurodegeneration and neuroinflammation.
    Bader V; Winklhofer KF
    Semin Cell Dev Biol; 2020 Mar; 99():163-171. PubMed ID: 31154011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.
    Golpich M; Amini E; Mohamed Z; Azman Ali R; Mohamed Ibrahim N; Ahmadiani A
    CNS Neurosci Ther; 2017 Jan; 23(1):5-22. PubMed ID: 27873462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration.
    Garabadu D; Agrawal N; Sharma A; Sharma S
    Behav Pharmacol; 2019 Dec; 30(8):642-652. PubMed ID: 31625975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.
    Park H; Kim J; Shin C; Lee S
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33924878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial quality control: Epigenetic signatures and therapeutic strategies.
    Ambekar T; Pawar J; Rathod R; Patel M; Fernandes V; Kumar R; Singh SB; Khatri DK
    Neurochem Int; 2021 Sep; 148():105095. PubMed ID: 34111479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Insight Into Mitochondrial Dysfunction and its Implications in Neurological Diseases.
    Waseem R; Shamsi A; Kazim SN; Islam A
    Curr Drug Targets; 2021; 22(14):1585-1595. PubMed ID: 33390128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review).
    Qin P; Sun Y; Li L
    Int J Mol Med; 2024 May; 53(5):. PubMed ID: 38577947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention.
    Angelova PR; Esteras N; Abramov AY
    Med Res Rev; 2021 Mar; 41(2):770-784. PubMed ID: 32656815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial Biology and Neurological Diseases.
    Arun S; Liu L; Donmez G
    Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.